Cargando…
Targeting BAP1 with small compound inhibitor for colon cancer treatment
BRCA1-associated protein-1 (BAP1) is a ubiquitin C-terminal hydrolase domain-containing deubiquitinase. The gene encoding BAP1 is mutated in various human cancers, including mesothelioma, uveal melanoma and renal cell carcinoma. BAP1 plays roles in many cancer-related cellular functions, including c...
Autores principales: | Kang, Minhwa, Park, Seul Gi, Lee, Shin-Ai, Kim, Soyi, Lee, Daye, Shirbhate, Mukesh Eknath, Youn, So-Yeon, Kim, Kwan Mook, Cha, Sun-Shin, Kwon, Jongbum |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9908887/ https://www.ncbi.nlm.nih.gov/pubmed/36754982 http://dx.doi.org/10.1038/s41598-023-29017-w |
Ejemplares similares
-
BAP1 as a guardian of genome stability: implications in human cancer
por: Kwon, Jongbum, et al.
Publicado: (2023) -
Cytotoxic activity of bromodomain inhibitor NVS-CECR2-1 on human cancer cells
por: Park, Seul Gi, et al.
Publicado: (2020) -
CHIP and BAP1 Act in Concert to Regulate INO80 Ubiquitination and Stability for DNA Replication
por: Seo, Hye-Ran, et al.
Publicado: (2021) -
Selected synthetic strategies to cyclophanes
por: Kotha, Sambasivarao, et al.
Publicado: (2015) -
To BaP or not to BaP? That is the question.
por: Goldstein, L S
Publicado: (2001)